VISCHER advises Mosanna Therapeutics on the deal. Mosanna Therapeutics AG closes an extension of the Seed Financing Round with the investors Supermoon Capital and High-Tech Gründerfonds...
Mosanna Therapeutics’s Seed Financing Round Extension
Mosanna Therapeutics AG’s Seed Financing Round
VISCHER advised Mosanna Therapeutics AG on the deal. Mosanna Therapeutics AG, a Basel-based biotechnology company developing the advanced small molecule MOS118 (formerly know as AVE0118) for...